DIVALPROEX SODIUM
- Product NDC
- 64679-974
- 11-digit product format
- 646790974
- Labeler code
- 64679
- Product ID
- 64679-974_a52fc616-0332-4ba1-bb2f-50e5ac8da6f9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DIVALPROEX SODIUM
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Wockhardt USA LLC.
- Application
- ANDA077296
- Marketing category
- ANDA
- Marketing start
- 2008-07-31
- Marketing end
- 0000-00-00
- Substance
- DIVALPROEX SODIUM
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64679-974-01 | 2024-11-14 | C162847 | 48780-1 | 9d75b9d0-7558-f424-e053-dadaa90a57ce | cd83f986-ec38-4e0e-aa03-3db5ad1629c6 |
| 64679-974-02 | 2024-11-14 | C162847 | 48780-1 | 9d75b9d0-7558-f424-e053-dadaa90a57ce | cd83f986-ec38-4e0e-aa03-3db5ad1629c6 |
| 64679-974-03 | 2024-11-14 | C162847 | 48780-1 | 9d75b9d0-7558-f424-e053-dadaa90a57ce | cd83f986-ec38-4e0e-aa03-3db5ad1629c6 |
| 64679-974-04 | 2024-11-14 | C162847 | 48780-1 | 9d75b9d0-7558-f424-e053-dadaa90a57ce | cd83f986-ec38-4e0e-aa03-3db5ad1629c6 |
| 64679-974-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7558-f424-e053-dadaa90a57ce | cd83f986-ec38-4e0e-aa03-3db5ad1629c6 |
| 64679-974-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7558-f424-e053-dadaa90a57ce | cd83f986-ec38-4e0e-aa03-3db5ad1629c6 |
| 64679-974-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7558-f424-e053-dadaa90a57ce | cd83f986-ec38-4e0e-aa03-3db5ad1629c6 |
| 64679-974-04 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-7558-f424-e053-dadaa90a57ce | cd83f986-ec38-4e0e-aa03-3db5ad1629c6 |